{"nctId":"NCT02350998","briefTitle":"Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration","startDateStruct":{"date":"2015-01"},"conditions":["Bilateral Middle Ear Effusion"],"count":33,"armGroups":[{"label":"OTO-201","type":"EXPERIMENTAL","interventionNames":["Drug: OTO-201"]}],"interventions":[{"name":"OTO-201","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria includes, but is not limited to:\n\n* Subject is a male or female aged 6 months to 17 years, inclusive\n* Subject has a clinical diagnosis of bilateral middle ear effusion requiring tympanostomy tube placement\n* Subject's caregiver is willing to comply with the protocol an attend all study visits\n\nExclusion Criteria includes, but is not limited to:\n\n* Subject has a history of prior ear or mastoid surgery, not including myringotomy or myringotomy with tympanostomy tube placement\n* Subject has a history of sensorineural hearing loss\n* Subject has been designated for any other surgical procedure that would occur concurrently with TT placement, such as, but not limited to adenoidectomy or tonsillectomy","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Otoscopic Examination: Auricle and Meatus","description":"Number of ears whose external ear and ear canal (auricle and meatus), when examined through an otoscope, appeared normal at Baseline and appeared abnormal at Day 29","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]},{"type":"PRIMARY","title":"Otoscopic Examination: Tympanic Membrane","description":"Number of ears whose ear drum (tympanic membrane), when examined through an otoscope, appeared normal at Baseline and appeared abnormal at Day 29","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Otoscopic Examination: Tube Patency","description":"Subjects with at least one ear tube patent (i.e., not blocked) at Day 29","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Feasibility of Administration","description":"Ease of administering OTO-201 through the tympanostomy tube: Number of subjects that investigators rated ease of administration as either \"easy\" or \"very easy\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["Nasopharyngitis","Ear Pain","Pyrexia","Upper Respiratory Infection","Nasal Congestion"]}}}